Literature DB >> 16885023

Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress.

Xin Wang1, Lee Zou, Tao Lu, Shilai Bao, Kristen E Hurov, Walter N Hittelman, Stephen J Elledge, Lei Li.   

Abstract

The ATR-mediated checkpoint is not only critical for responding to genotoxic stress but also essential for cell proliferation. The RFC-related checkpoint protein Rad17, a phosphorylation substrate of ATR, is critical for ATR-mediated checkpoint signaling and cell survival. Here, we show that phosphorylation of Rad17 by ATR is important for genomic stability and restraint of S phase but is not essential for cell survival. The phosphomutant Rad17AA exhibits distinct defects in hydroxyurea- (HU) and ultraviolet- (UV) induced Chk1 activation, indicating that separate Rad17 functions are required differently in response to different types of replication interference. Although cells expressing Rad17AA can initiate Chk1 phosphorylation after HU treatment, they fail to sustain Chk1 phosphorylation after withdrawal of HU and are profoundly sensitive to HU. Importantly, we found that phosphorylated Rad17 interacts with Claspin and regulates its phosphorylation. These findings reveal a phosphorylation-dependent function of Rad17 in an ATR-Rad17-Claspin-Chk1-signaling cascade that responds to specific replication stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885023     DOI: 10.1016/j.molcel.2006.06.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

1.  The conserved C terminus of Claspin interacts with Rad9 and promotes rapid activation of Chk1.

Authors:  Shizhou Liu; Na Song; Lee Zou
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

2.  Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress.

Authors:  Liyong Zhang; Chi-Hoon Park; Jing Wu; Hyun Kim; Weijun Liu; Takeo Fujita; Manimalha Balasubramani; Emanuel M Schreiber; Xiao-Fan Wang; Yong Wan
Journal:  EMBO J       Date:  2010-04-27       Impact factor: 11.598

Review 3.  APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity.

Authors:  Xinxian Qiao; Liyong Zhang; Armin M Gamper; Takeo Fujita; Yong Wan
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

4.  Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.

Authors:  Xiaojun Liu; Yaqing Wang; Sherri Benaissa; Akira Matsuda; Hagop Kantarjian; Zeev Estrov; William Plunkett
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

Review 5.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

6.  NONO regulates the intra-S-phase checkpoint in response to UV radiation.

Authors:  L Alfano; C Costa; A Caporaso; A Altieri; P Indovina; M Macaluso; A Giordano; F Pentimalli
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 7.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

8.  Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Authors:  Ge Li; Hyeon U Park; Dong Liang; Richard Y Zhao
Journal:  Retrovirology       Date:  2010-07-07       Impact factor: 4.602

9.  Rad17 plays a central role in establishment of the interaction between TopBP1 and the Rad9-Hus1-Rad1 complex at stalled replication forks.

Authors:  Joon Lee; William G Dunphy
Journal:  Mol Biol Cell       Date:  2010-01-28       Impact factor: 4.138

10.  Cohesin acetylation speeds the replication fork.

Authors:  Marie-Emilie Terret; Rebecca Sherwood; Sadia Rahman; Jun Qin; Prasad V Jallepalli
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.